Invasive Pneumococcal Infections Among Moroccan Children: Pneumococcal Vaccination Challenges in the Mature Vaccine

Clinical Laboratory
|September 11, 2024
PubMed

Insights

Invasive pneumococcal disease (IPD) persists in Moroccan children, with non-vaccine serotypes like 3 and 19A posing challenges. Updated vaccination strategies are crucial for effective prevention.

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Streptococcus pneumoniae causes significant global morbidity and mortality, particularly in vulnerable populations.
  • Serotype replacement remains a challenge despite vaccination, necessitating updated public health strategies for invasive pneumococcal diseases (IPD).

Purpose of the Study:

  • To assess pneumococcal serotype distribution and antibiotic sensitivity in hospitalized children in Morocco.
  • To evaluate the impact of current vaccination coverage on IPD epidemiology in the post-vaccination era.

Main Methods:

  • Analysis of 74 Streptococcus pneumoniae strains from hospitalized children between 2019 and 2022.
  • Assessment of serotype prevalence, antibiotic susceptibility, and vaccine coverage (PCV-10, PCV-13).

Main Results:

  • Meningitis/meningo-encephalitis was prevalent in 66% of cases, with serotypes 3, 19A, 6B, 14, and 11 being most common.
  • PCV-10 and PCV-13 coverage was 20.27% and 56.75%, respectively. 43% of strains were non-vaccine types, with serotypes 3 and 19 contributing significantly to infections.
  • Penicillin non-susceptible Streptococcus pneumoniae (PNSP) accounted for 31.3% of strains, predominantly non-vaccine types.

Conclusions:

  • IPD remains a significant concern in Moroccan children, with notable challenges from non-vaccine serotypes.
  • The efficacy of PCV-13 against prevalent non-vaccine serotypes (3, 19A) requires ongoing evaluation.
  • Continuous surveillance and adaptive vaccination strategies are essential to address serotype replacement and improve IPD prevention.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
188
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345